Smart drug and biotech companies keep the FDA abreast of their clinical trial program throughout the long drug-development process.
11/20/09 - 06:01 AM EST
Pfizer to Begin Selling Generics in Japan
- Tickers in this article:
- PFE
Pfizer plans to start selling generic drugs in Japan beginning in 2011, a spokesman said, according to reports.
11/19/09 - 12:39 AM EST
U.S. Sees Low Demand for BioCryst Flu Drug
Peaking flu season could mean no need for further peramivir orders.
11/18/09 - 11:12 AM EST
Drugmakers' Differences: Analyst's Toolkit
Pharmaceutical companies require their own metrics of evaluation. Sanofi, which looks strong in some ways, comes across as risky in others.
11/18/09 - 05:00 AM EST
Another Genzyme Drug Goes Kaboom: BioBuzz
Company halts development of kidney disease drug following poor test results.
11/18/09 - 08:05 AM EST
Vivus Seeks Faster ED Drug: Biobuzz
Company says ED drug met all goals in phase III study.
11/18/09 - 06:42 AM EST
Isis Cholesterol Drug Effective, but Safety a Worry: BioBuzz
Mipomersen lowers cholesterol but not without liver side effects.
11/17/09 - 10:56 AM EST
InterMune Hep C Drug Hit With Liver Tox Worry: BioBuzz
Safety monitors force change to mid-stage study of ITMN-191
11/17/09 - 09:11 AM EST
NEW YORK (TheStreet) -- Auxilium CEO Armando Anido tells TSC's Debra Borchardt of the future plans for its soon-to-be-launched drug Xiaflex for collagen based diseases.
11/16/09 - 09:00 AM EST
Poniard's CEO Pulls a Belichick: BioBuzz
Risky late-game call puts Poniard in a deep financial hole.
11/16/09 - 11:59 AM EST
A Closer Look at Cardium's Wound-Healing Drug: BioBuzz
Is it the drug or the gel that worked best in a phase II study?
11/16/09 - 10:51 AM EST
Cell Therapeutics Lavishes Free Stock on Execs: BioBuzz
'Retention' bonus awarded to CEO Jim Bianco, his management team and directors.
11/16/09 - 09:23 AM EST
Connect with TheStreet